Follow our Facebook page for updates! | Click here to donate or volunteer

AKCCHF grant #00982 (closed)

Evaluation of Efficacy of Fasaret in Dogs with Osteosarcoma

Don Bellgrau, PhD, ApopLogic Pharmaceuticals LLC

Final Report

Publication:

Modiano JF, Bellgrau et al. Inflammation, Apoptosis, and Necrosis Induced by Neoadjuvant Fas Ligand Gene Therapy Improves Survival ofDogs With Spontaneous Bone Cancer. 2012. Molecular Therapy 20: 2234-2243.